Literature DB >> 9614526

Assessment of visual function in idiopathic intracranial hypertension: a prospective study.

F J Rowe1, N J Sarkies.   

Abstract

The visual function of 35 patients with a diagnosis of idiopathic intracranial hypertension was assessed prospectively over a 3 year period. In assessing the visual function of cases of idiopathic intracranial hypertension a number of tests were employed including visual field assessment with Humphrey and Goldmann perimeters and documentation of visual acuity and contrast sensitivity. Loss of visual function is the only serious complication and may occur early or late in the course of the condition. An appropriate and sensitive clinical assessment regime is therefore of importance in the outpatient situation. Visual field assessment was documented as the most sensitive to detection of visual loss, with statistically greater sensitivity in comparison with visual acuity and contrast sensitivity testing. Detection of asymptomatic visual loss indicates the necessity for visual monitoring to ensure detection of insidious visual loss. The types of visual field defects noted in this study were typical of anterior optic nerve pathology of raised intracranial pressure and commonly included arcuate defects, nasal steps and global constriction. Visual loss was noted at presentation and during follow-up in up to 87% of patients using Goldmann perimetry and up to 82% of patients using Humphrey perimetry. The visual status improved significantly throughout the follow-up period and the final visual outcome was excellent or good in 83% of patients.

Entities:  

Mesh:

Year:  1998        PMID: 9614526     DOI: 10.1038/eye.1998.18

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN: 0950-222X            Impact factor:   3.775


  38 in total

Review 1.  New developments in idiopathic intracranial hypertension.

Authors:  R K Shin; L J Balcer
Journal:  Curr Neurol Neurosci Rep       Date:  2001-09       Impact factor: 5.081

2.  Visual field loss in children with craniosynostosis.

Authors:  Alki Liasis; Bronwen Walters; Dorothy Thompson; Kate Smith; Richard Hayward; Ken K Nischal
Journal:  Childs Nerv Syst       Date:  2011-01-29       Impact factor: 1.475

3.  The headache of teenage acne.

Authors:  Tania Cellucci; Liesly Lee; David N Juurlink
Journal:  CMAJ       Date:  2004-06-08       Impact factor: 8.262

4.  Idiopathic intracranial hypertension is not benign: a long-term outcome study.

Authors:  Hanne M Yri; Marianne Wegener; Birgit Sander; Rigmor Jensen
Journal:  J Neurol       Date:  2011-10-19       Impact factor: 4.849

5.  Diagnostic value of optical coherence tomography for intracranial pressure in idiopathic intracranial hypertension.

Authors:  Maren Skau; Hanne Yri; Birgit Sander; Thomas A Gerds; Dan Milea; Rigmor Jensen
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2012-05-18       Impact factor: 3.117

6.  The Photopic Negative Response in Idiopathic Intracranial Hypertension.

Authors:  Heather E Moss; Jason C Park; J Jason McAnany
Journal:  Invest Ophthalmol Vis Sci       Date:  2015-06       Impact factor: 4.799

7.  The idiopathic intracranial hypertension treatment trial: clinical profile at baseline.

Authors:  Michael Wall; Mark J Kupersmith; Karl D Kieburtz; James J Corbett; Steven E Feldon; Deborah I Friedman; David M Katz; John L Keltner; Eleanor B Schron; Michael P McDermott
Journal:  JAMA Neurol       Date:  2014-06       Impact factor: 18.302

Review 8.  Cerebral venous sinus stenting for pseudotumor cerebri: A review.

Authors:  Sivashakthi Kanagalingam; Prem S Subramanian
Journal:  Saudi J Ophthalmol       Date:  2014-09-27

9.  Electroretinography in idiopathic intracranial hypertension: comparison of the pattern ERG and the photopic negative response.

Authors:  Jason C Park; Heather E Moss; J Jason McAnany
Journal:  Doc Ophthalmol       Date:  2017-11-14       Impact factor: 2.379

10.  Clinical profile, evaluation, management and visual outcome of idiopathic intracranial hypertension in a neuro-ophthalmology clinic of a tertiary referral ophthalmic center in India.

Authors:  S Ambika; Deepak Arjundas; Veena Noronha
Journal:  Ann Indian Acad Neurol       Date:  2010-01       Impact factor: 1.383

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.